L Falk1, H Fredlund, J S Jensen. 1. Department of Dermatology and Venereology, University Hospital, Orebro, SE -701 85 Orebro, Sweden. lars.falk@orebroll.se
Abstract
OBJECTIVES: To study the prevalence, symptoms, and signs of Mycoplasma genitalium and Chlamydia trachomatis infections in women attending a Swedish STD clinic, accessible for both sexes, and in a group of young women called in the cervical cancer screening programme. METHODS: A cross sectional study among female STD clinic attendees in Orebro and a study among women called for Papanicolaou smear screening. Attendees were examined for urethritis and cervicitis. First void urine and endocervical samples were tested for M genitalium and C trachomatis. RESULTS: The prevalence of C trachomatis and M genitalium in the STD clinic population was 10% (45/465) and 6% (26/461), respectively. Dual infection was diagnosed in four women. In the cancer screening group of women the corresponding prevalence was 2% (1/59) and 0%, respectively. Among the STD clinic attendees there were no significant differences in symptoms (32% v 23%, RR 1.4, 95% CI 0.6 to 3.4) or signs (71% v 50%, RR 1.4, 95% CI 0.9 to 2.3) between C trachomatis and M genitalium infections. Microscopic signs of cervicitis were significantly more common among M genitalium and C trachomatis infected women than in the cancer screening group of women. 56% (15/27) of male partners of M genitalium infected women were infected with M genitalium compared to 59% of male partners of C trachomatis infected women who were infected with C trachomatis (p = 0.80). CONCLUSIONS: M genitalium is a common infection associated with cervicitis and with a high prevalence of infected sexual partners supporting its role as a cause of sexually transmitted infection.
OBJECTIVES: To study the prevalence, symptoms, and signs of Mycoplasma genitalium and Chlamydia trachomatis infections in women attending a Swedish STD clinic, accessible for both sexes, and in a group of young women called in the cervical cancer screening programme. METHODS: A cross sectional study among female STD clinic attendees in Orebro and a study among women called for Papanicolaou smear screening. Attendees were examined for urethritis and cervicitis. First void urine and endocervical samples were tested for M genitalium and C trachomatis. RESULTS: The prevalence of C trachomatis and M genitalium in the STD clinic population was 10% (45/465) and 6% (26/461), respectively. Dual infection was diagnosed in four women. In the cancer screening group of women the corresponding prevalence was 2% (1/59) and 0%, respectively. Among the STD clinic attendees there were no significant differences in symptoms (32% v 23%, RR 1.4, 95% CI 0.6 to 3.4) or signs (71% v 50%, RR 1.4, 95% CI 0.9 to 2.3) between C trachomatis and M genitalium infections. Microscopic signs of cervicitis were significantly more common among M genitalium and C trachomatis infectedwomen than in the cancer screening group of women. 56% (15/27) of male partners of M genitalium infected women were infected with M genitalium compared to 59% of male partners of C trachomatis infectedwomen who were infected with C trachomatis (p = 0.80). CONCLUSIONS: M genitalium is a common infection associated with cervicitis and with a high prevalence of infected sexual partners supporting its role as a cause of sexually transmitted infection.
Authors: G Johannisson; Y Enström; G B Löwhagen; V Nagy; K Ryberg; S Seeberg; C Welinder-Olsson Journal: Int J STD AIDS Date: 2000-05 Impact factor: 1.359
Authors: J Pépin; F Sobéla; S Deslandes; M Alary; K Wegner; N Khonde; F Kintin; A Kamuragiye; M Sylla; P J Zerbo; E Baganizi; A Koné; F Kane; B Mâsse; P Viens; E Frost Journal: Bull World Health Organ Date: 2001 Impact factor: 9.408
Authors: H F Clausen; J Fedder; M Drasbek; P K Nielsen; B Toft; H J Ingerslev; S Birkelund; G Christiansen Journal: Hum Reprod Date: 2001-09 Impact factor: 6.918
Authors: Lisa E Manhart; Cathy W Critchlow; King K Holmes; Susan M Dutro; David A Eschenbach; Claire E Stevens; Patricia A Totten Journal: J Infect Dis Date: 2003-01-29 Impact factor: 5.226
Authors: Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet Journal: Clin Infect Dis Date: 2003-02-07 Impact factor: 9.079
Authors: Lyndsey R Buckner; Danny J Schust; Jian Ding; Takeshi Nagamatsu; Wandy Beatty; Theresa L Chang; Sheila J Greene; Maria E Lewis; Bernardo Ruiz; Stacey L Holman; Rae Ann Spagnuolo; Richard B Pyles; Alison J Quayle Journal: J Reprod Immunol Date: 2011-09-22 Impact factor: 4.054
Authors: Jane Hitti; Pedro Garcia; Patricia Totten; Kathleen Paul; Sabina Astete; King K Holmes Journal: Sex Transm Dis Date: 2010-02 Impact factor: 2.830
Authors: Victoria L Mobley; Marcia M Hobbs; Karen Lau; Barbara S Weinbaum; Damon K Getman; Arlene C Seña Journal: Sex Transm Dis Date: 2012-09 Impact factor: 2.830